World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

BRUCELLOSIS OSTEOARTHRITIS: A LOOK AT THE PREVALENCE, DIAGNOSIS AND TREATMENT IN THE MODERN WORLD

Sunny Saurya, Adityakiran Das, Olga G. Goryacheva and Emmanuel Ifeanyi Obeagu*

ABSTRACT

Brucellosis osteoarthritis is a prominent and debilitating manifestation of human brucellosis, a globally prevalent zoonotic infection caused by Brucella species. The condition primarily affects the musculoskeletal system, with the spine, sacroiliac joints, and large peripheral joints being the most commonly involved. In endemic regions, delayed diagnosis and inadequate treatment often contribute to high morbidity, chronic pain, and permanent joint damage. The disease remains underrecognized due to its non-specific clinical presentation and resemblance to other inflammatory or infectious arthropathies. Diagnosis of brucellosis osteoarthritis requires a multidisciplinary approach combining clinical assessment, serological testing, imaging, and microbial cultures. Serological assays such as the standard agglutination test and ELISA are crucial for early detection, while imaging modalities like MRI aid in evaluating the extent of joint and bone involvement. Culture confirmation remains the gold standard but is limited by low sensitivity and prolonged incubation times. In chronic or relapsing cases, histopathological analysis and advanced imaging are invaluable.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR